Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
Launched by BOSTON CHILDREN'S HOSPITAL · Sep 25, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the quality of indoor air can affect the breathing problems and lung function of school-aged children who have bronchopulmonary dysplasia (BPD). BPD is a condition that affects newborns, usually those born prematurely, and can lead to chronic lung issues. The researchers want to understand how different indoor environments might impact the respiratory health of these children as they grow.
To participate in this study, children need to be between 6 and 12 years old, born before 32 weeks of pregnancy, and diagnosed with BPD or have needed oxygen or breathing support for more than 28 days. The trial is currently looking for participants and welcomes children of all genders. Participating families can expect to share information about their child's breathing and indoor living conditions, which may help improve understanding of how to support better lung health in children with BPD. It’s important to note that children with certain major surgeries or disabilities that prevent them from doing breathing tests cannot participate, and families planning to move out of state soon will also be excluded from the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children 6-12 yrs old
- • born \<32 wks gestational age
- • diagnosis of BPD or \> 28 days of oxygen or respiratory support
- Exclusion Criteria:
- • major airway or chest surgery
- • physical or mental impairment that will prevent from doing spirometry
- • plans to move out of state within the next 9 months
About Boston Children's Hospital
Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Jonathan Gaffin, MD. MMSc.
Principal Investigator
Boston Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials